CEP55 is involved in multiple malignancy risk signatures for predicting cancer prognosis, progression, and chemotherapy response, and is within the main 70 overexpressed genes in cancers with chromosomal instability (the CIN70 signature) that are frequently used to predict clinical prognoses and distant metastases (Carter et al., 2006). The gene discussed is CEP55; the disease is cancer.